Science

4 VCs and 5 funds investing in Science

VCs investing in Science

Albert Wenger

Partner

85%

Union Square Ventures (USV)

Check: USV states that the firm writes $1 million to $30 million checks and invests from the earliest stages through the full company journey. This is a firm-wide range, not Albert's personal check authority; decisions are discussed collectively without a formal vote.

Albert is a thesis-driven generalist investing at the edge of large markets under technological and societal pressure. His current work emphasizes AI-enabled scientific discovery, robotics that can operate reliably in complex physical environments, resilient energy and civil infrastructure, and products that expand human agency. Across these areas he looks for compounding data or participation loops and systems that turn rapidly improving technical capabilities into durable real-world utility.

Pre-SeedSeedSeries A

Kristen Brillantes

Head of Programs and Community

80%

Character Capital

Check: Up to $2M from the main fund; Character Labs publishes a separate $200K-for-5% offer.

Kristen Brillantes is listed in a Head of Programs and Community capacity at Character Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

InceptionPre-SeedSeed

John Zeratsky

Co-Founder and General Partner

80%

Character Capital

Check: Up to $2M from the main fund; Character Labs publishes a separate $200K-for-5% offer.

John Zeratsky invests or supports investments through Character Capital's published strategy: Back frontier AI and software companies changing science, medicine, industry, business and commerce, with concentrated support in the earliest stages.

InceptionPre-SeedSeed

Eli Blee-Goldman

Co-Founder and General Partner

80%

Character Capital

Check: Up to $2M from the main fund; Character Labs publishes a separate $200K-for-5% offer.

Eli Blee-Goldman invests or supports investments through Character Capital's published strategy: Back frontier AI and software companies changing science, medicine, industry, business and commerce, with concentrated support in the earliest stages.

InceptionPre-SeedSeed

Funds focused on Science